CliffBio
small molecule

MINIRIN

DESMOPRESSIN ACETATE

Loss of exclusivity—loss of exclusivity
CompanyFerring Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameMINIRIN
Active ingredientDESMOPRESSIN ACETATE
Strength0.01MG/SPRAY
Dosage formSPRAY, METERED
RouteNASAL
ModalitySmall molecule
FDA approvalSeptember 2002
Marketing statusDISCN

More from Ferring Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

MINIRIN patent cliff — loss of exclusivity — | CliffBio